The prevalence of the autoimmune markers in chronic hepatitis C patients and their impact on treatment by interferon and clinical Profile

Immunologic and Extra hepatic Manifestations of HCV Infection

Diabetic chronic HCV patients and their response to interferon therapy

Prevalence of thyroid dysfunction in Egyptianchronic hepatitis C patients treated with pegylated interferon and ribavirin

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Study of insulin resistance (IR) as a predictor for response to interferon based therapy in patients with chronic HCV

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Study of non-symptomatizing patients with positive anti-HCV antibodies

Serum hepcidin levels in chronic hepatitis C patients

Islet cell antibodies and its relation to Diabetes mellitus in patients with chronic hepatitis B and C